Treat-to-Target and Minimal Disease Activity Achievement with Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Multicenter Real-World Study in China [supplement]
收藏官方服务：
资源简介：
Supplemental tables for "Treat-to-Target and Minimal Disease Activity Achievement with Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Multicenter Real-World Study in China"
提供机构：
Mendeley Data创建时间：
2025-05-02
